Koshi Mimori

425 total citations
16 papers, 361 citations indexed

About

Koshi Mimori is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Koshi Mimori has authored 16 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Oncology and 3 papers in Surgery. Recurrent topics in Koshi Mimori's work include Amino Acid Enzymes and Metabolism (3 papers), Peptidase Inhibition and Analysis (3 papers) and Polyamine Metabolism and Applications (3 papers). Koshi Mimori is often cited by papers focused on Amino Acid Enzymes and Metabolism (3 papers), Peptidase Inhibition and Analysis (3 papers) and Polyamine Metabolism and Applications (3 papers). Koshi Mimori collaborates with scholars based in Japan and United States. Koshi Mimori's co-authors include Masaki Mori, Hiroshi Inoue, Yoïchi Tanaka, Masaki Mori, Toshihiko Masuda, Keiji Yoshinaga, Masahiro Okamoto, Hiroaki Ueo, Keishi Yamashita and Tatsuo Fujie and has published in prestigious journals such as Annals of Oncology, International Journal of Cancer and Journal of Clinical Pathology.

In The Last Decade

Koshi Mimori

12 papers receiving 356 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Koshi Mimori Japan	10	150	142	94	75	75	16	361
K Ito Japan	9	94 0.6×	196 1.4×	92 1.0×	48 0.6×	40 0.5×	15	351
Shoichiro Mukai Japan	12	117 0.8×	173 1.2×	97 1.0×	90 1.2×	36 0.5×	54	438
K H Chung Japan	12	249 1.7×	166 1.2×	107 1.1×	82 1.1×	74 1.0×	20	497
Ji-Hai Yu China	12	140 0.9×	276 1.9×	143 1.5×	42 0.6×	32 0.4×	19	483
Hae Yoen Jung South Korea	11	78 0.5×	183 1.3×	58 0.6×	41 0.5×	64 0.9×	20	309
Hongming Qiu United States	9	153 1.0×	157 1.1×	73 0.8×	91 1.2×	101 1.3×	14	356
Javier Pozas Spain	12	190 1.3×	137 1.0×	52 0.6×	44 0.6×	54 0.7×	24	375
Samornmas Kanngurn Thailand	11	134 0.9×	239 1.7×	101 1.1×	80 1.1×	100 1.3×	25	442
Shao-Chieh Lin Taiwan	11	114 0.8×	162 1.1×	116 1.2×	48 0.6×	47 0.6×	16	374
Mikiya Kashiwagi Switzerland	7	163 1.1×	147 1.0×	51 0.5×	92 1.2×	27 0.4×	8	339

Countries citing papers authored by Koshi Mimori

Since Specialization

Citations

This map shows the geographic impact of Koshi Mimori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koshi Mimori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koshi Mimori more than expected).

Fields of papers citing papers by Koshi Mimori

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koshi Mimori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koshi Mimori. The network helps show where Koshi Mimori may publish in the future.

Co-authorship network of co-authors of Koshi Mimori

This figure shows the co-authorship network connecting the top 25 collaborators of Koshi Mimori. A scholar is included among the top collaborators of Koshi Mimori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koshi Mimori. Koshi Mimori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Otsu, Hajime, Satoshi Higuchi, Kosuke Hirose, et al.. (2025). Clinical and Biological Significance of Sodium Channel Modifier 1 as a Component of the Minor Spliceosome in Hepatocellular Carcinoma. PubMed. 32(6). 4508–4519.

Higuchi, Satoshi, Hajime Otsu, Takaaki Masuda, et al.. (2025). SEC61G promotes colorectal cancer progression by regulating cytosolic Ca2+ concentration. Journal of Gastroenterology. 60(9). 1091–1107.

Otsu, Hajime, Satoshi Higuchi, Satoshi Shibuta, et al.. (2025). VPS45 promotes the progression of hepatocellular carcinoma by recycling β1 integrin to the cell membrane via the endocytic pathway. Journal of Gastroenterology. 60(9). 1157–1173.

Otsu, Hajime, Takaaki Masuda, Hiroshi Saeki, et al.. (2025). Cytotoxic Anti-tumor Drugs and Tumor-Associated Macrophages Synergistically Surge PD-L1 Expression in Esophageal Squamous Cell Carcinoma. Annals of Surgical Oncology. 32(10). 7860–7873.

Yokobori, Takehiko, Shigeyoshi Suzuki, Tatsuya Miyazaki, et al.. (2015). Intestinal epithelial culture under an air-liquid interface: a tool for studying human and mouse esophagi. Diseases of the Esophagus. 29(7). 843–847. 2 indexed citations

Sudo, Tomoya, Koshi Mimori, Hisashi Nagahara, et al.. (2006). Identification of EGFR mutations in esophageal cancer. European Journal of Surgical Oncology. 33(1). 44–48. 32 indexed citations

Mimori, Koshi, Yoïchi Tanaka, Keiji Yoshinaga, et al.. (2004). Clinical significance of the overexpression of the candidate oncogene CYP24 in esophageal cancer. Annals of Oncology. 15(2). 236–241. 85 indexed citations

Inoué, Hiroshi, Koshi Mimori, Toru Utsunomiya, et al.. (2001). Heparanase expression in clinical digestive malignancies. Oncology Reports. 8(3). 539–42. 14 indexed citations

Kinoshita, Yoshiaki, Sadafumi Tamiya, Yoshihisa Oda, et al.. (2001). Establishment and characterization of malignant rhabdoid tumor of the kidney.. Oncology Reports. 8(1). 43–8. 14 indexed citations

10.

Mimori, Koshi, et al.. (2000). Prognostic impact of tissue inhibitor of matrix metalloproteinase-1 in esophageal carcinoma. International Journal of Cancer. 88(4). 575–578. 23 indexed citations

11.

Tanaka, Yoïchi, et al.. (1999). Increased expression of ornithine decarboxylase messenger RNA in human esophageal carcinoma.. PubMed. 5(12). 4073–8. 20 indexed citations

12.

Mimori, Koshi, Masaki Mori, Takuya Shiraishi, et al.. (1998). Expression of ornithine decarboxylase mRNA and c-myc mRNA in breast tumours.. International Journal of Oncology. 12(3). 597–601. 15 indexed citations

13.

Mimori, Koshi, Masaki Mori, Tatsuo Fujie, et al.. (1997). Analysis of ornithine decarboxylase messenger ribonucleic acid expression in colorectal carcinoma. Diseases of the Colon & Rectum. 40(9). 1095–1100. 6 indexed citations

14.

Mori, Masaki, Koshi Mimori, Tatsuo Fujie, et al.. (1997). Analysis of MT1-MMP and MMP2 expression in human gastric cancers. International Journal of Cancer. 74(3). 316–321. 83 indexed citations

15.

Mori, Masaki, et al.. (1995). Chromogranin positive cells in colorectal carcinoma and transitional mucosa.. Journal of Clinical Pathology. 48(8). 754–758. 34 indexed citations

16.

Kuwano, Hiroyuki, Noriaki Sadanaga, Tadahiro Nozoe, et al.. (1994). Univariate and multivariate analyses of the prognostic significance of discontinuous intramural metastasis in patients with esophageal cancer. Journal of Surgical Oncology. 57(1). 17–21. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact